Medicom Conference Report SABCS 2022最新文献

筛选
英文 中文
Racial disparity in the tumour microenvironment 肿瘤微环境中的种族差异
Medicom Conference Report SABCS 2022 Pub Date : 2023-02-01 DOI: 10.55788/53c2cea1
Marten Dooper
{"title":"Racial disparity in the tumour microenvironment","authors":"Marten Dooper","doi":"10.55788/53c2cea1","DOIUrl":"https://doi.org/10.55788/53c2cea1","url":null,"abstract":"","PeriodicalId":163367,"journal":{"name":"Medicom Conference Report SABCS 2022","volume":"22 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"115607965","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
ZNF689 deficiency promotes intratumour heterogeneity and resistance to immune checkpoint blockade in TNBC ZNF689缺乏促进TNBC肿瘤内异质性和免疫检查点阻断的抵抗
Medicom Conference Report SABCS 2022 Pub Date : 2023-02-01 DOI: 10.55788/5176186e
Marten Dooper
{"title":"ZNF689 deficiency promotes intratumour heterogeneity and resistance to immune checkpoint blockade in TNBC","authors":"Marten Dooper","doi":"10.55788/5176186e","DOIUrl":"https://doi.org/10.55788/5176186e","url":null,"abstract":"","PeriodicalId":163367,"journal":{"name":"Medicom Conference Report SABCS 2022","volume":"18 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"116641631","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Resistance to CDK4/6 inhibitors is likely due to expansion of pre-existing resistant clones 对CDK4/6抑制剂的耐药性可能是由于先前存在的耐药克隆的扩大
Medicom Conference Report SABCS 2022 Pub Date : 2023-02-01 DOI: 10.55788/a6790cd2
Marten Dooper
{"title":"Resistance to CDK4/6 inhibitors is likely due to expansion of pre-existing resistant clones","authors":"Marten Dooper","doi":"10.55788/a6790cd2","DOIUrl":"https://doi.org/10.55788/a6790cd2","url":null,"abstract":"","PeriodicalId":163367,"journal":{"name":"Medicom Conference Report SABCS 2022","volume":"59 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"120897088","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Low-dose tamoxifen still prevents recurrence from non-invasive breast cancer 低剂量他莫昔芬仍然可以预防非侵袭性乳腺癌的复发
Medicom Conference Report SABCS 2022 Pub Date : 2023-02-01 DOI: 10.55788/b808e247
Marten Dooper
{"title":"Low-dose tamoxifen still prevents recurrence from non-invasive breast cancer","authors":"Marten Dooper","doi":"10.55788/b808e247","DOIUrl":"https://doi.org/10.55788/b808e247","url":null,"abstract":"","PeriodicalId":163367,"journal":{"name":"Medicom Conference Report SABCS 2022","volume":"1 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"131117337","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
MammaPrint test predictive for benefit of extended endocrine therapy mamaprint测试预测延长内分泌治疗的益处
Medicom Conference Report SABCS 2022 Pub Date : 2023-02-01 DOI: 10.55788/9a93a95b
Marten Dooper
{"title":"MammaPrint test predictive for benefit of extended endocrine therapy","authors":"Marten Dooper","doi":"10.55788/9a93a95b","DOIUrl":"https://doi.org/10.55788/9a93a95b","url":null,"abstract":"","PeriodicalId":163367,"journal":{"name":"Medicom Conference Report SABCS 2022","volume":"20 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"128613801","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Trastuzumab deruxtecan effective in both second-line and neoadjuvant setting 曲妥珠单抗deruxtecan在二线和新辅助设置有效
Medicom Conference Report SABCS 2022 Pub Date : 2023-02-01 DOI: 10.55788/2556a6fb
Marten Dooper
{"title":"Trastuzumab deruxtecan effective in both second-line and neoadjuvant setting","authors":"Marten Dooper","doi":"10.55788/2556a6fb","DOIUrl":"https://doi.org/10.55788/2556a6fb","url":null,"abstract":"","PeriodicalId":163367,"journal":{"name":"Medicom Conference Report SABCS 2022","volume":"20 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"117196682","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
First-line ribociclib plus endocrine therapy outperforms combination chemotherapy 一线核糖素加内分泌治疗优于联合化疗
Medicom Conference Report SABCS 2022 Pub Date : 2023-02-01 DOI: 10.55788/3417c453
Marten Dooper
{"title":"First-line ribociclib plus endocrine therapy outperforms combination chemotherapy","authors":"Marten Dooper","doi":"10.55788/3417c453","DOIUrl":"https://doi.org/10.55788/3417c453","url":null,"abstract":"","PeriodicalId":163367,"journal":{"name":"Medicom Conference Report SABCS 2022","volume":"136 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"133634155","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Chemo-endocrine therapy worse for cognition than endocrine therapy alone 化疗-内分泌联合治疗对认知的影响较单纯内分泌治疗差
Medicom Conference Report SABCS 2022 Pub Date : 2023-02-01 DOI: 10.55788/2ec9a13b
Marten Dooper
{"title":"Chemo-endocrine therapy worse for cognition than endocrine therapy alone","authors":"Marten Dooper","doi":"10.55788/2ec9a13b","DOIUrl":"https://doi.org/10.55788/2ec9a13b","url":null,"abstract":"","PeriodicalId":163367,"journal":{"name":"Medicom Conference Report SABCS 2022","volume":"48 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"124174829","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Oestradiol represses anti-tumoural immune response to promote progression of brain metastases 雌二醇抑制抗肿瘤免疫反应,促进脑转移的进展
Medicom Conference Report SABCS 2022 Pub Date : 2023-02-01 DOI: 10.55788/12a6e09d
Marten Dooper
{"title":"Oestradiol represses anti-tumoural immune response to promote progression of brain metastases","authors":"Marten Dooper","doi":"10.55788/12a6e09d","DOIUrl":"https://doi.org/10.55788/12a6e09d","url":null,"abstract":"","PeriodicalId":163367,"journal":{"name":"Medicom Conference Report SABCS 2022","volume":"31 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"121875510","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Germline pathogenic variants for breast cancer also increase contralateral breast cancer risk 乳腺癌的种系致病变异也会增加患对侧乳腺癌的风险
Medicom Conference Report SABCS 2022 Pub Date : 2023-02-01 DOI: 10.55788/83b96e40
Marten Dooper
{"title":"Germline pathogenic variants for breast cancer also increase contralateral breast cancer risk","authors":"Marten Dooper","doi":"10.55788/83b96e40","DOIUrl":"https://doi.org/10.55788/83b96e40","url":null,"abstract":"","PeriodicalId":163367,"journal":{"name":"Medicom Conference Report SABCS 2022","volume":"143 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"115808751","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信